Citron Research Takes it to Intuitive Surgical (ISRG) Again

October 7, 2013 3:35 PM EDT Send to a Friend
Intuitive Surgical (Nasdaq: ISRG) is up Monday amid Citron Research releasing >another bearish report surrounding new data for the company.

In particular, Citron accuses Intuitive Surgical of misusing statistical data and thinks the company is disregarding the FDA’s own guidance with regard to the use of the MAUDE dataset. The firm notes: September MAUDE reports have just been posted. Another 102 injury-type reports and another 4 death-type reports. This exceeds August's record high, which was itself four times any previous reporting period in the company's history.

For the full report, click here. Shares of Intuitive are up 4.4 percent on the session.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Insiders' Blog

Related Entities

Citron Research

Add Your Comment